Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Cell Infect Microbiol. 2022 Oct 6;12:983027. doi: 10.3389/fcimb.2022.983027. eCollection 2022.
OBJECTIVE: To explore the effect of probiotics combined with prebiotics on clinical hypothyroidism during pregnancy combined with small intestinal bacterial overgrowth. METHODS: (1) In total, 441 pregnant women were included in this study. A total of 231 patients with clinical hypothyroidism during the second trimester of pregnancy and 210 normal pregnant women were enrolled in the lactulose methane-hydrogen breath test. The positive rate of intestinal bacterial overgrowth (SIBO), gastrointestinal symptoms, thyroid function and inflammatory factors were compared between the two groups by chi-square test and two independent sample t-test. (2) SIBO-positive patients in the clinical hypothyroidism group during pregnancy (n=112) were treated with probiotics combined with prebiotics based on conventional levothyroxine sodium tablets treatment. The changes in the methane-hydrogen breath test, gastrointestinal symptoms, thyroid function and inflammatory factors were compared before treatment (G0) and 21 days after treatment (G21) by chi-square test and paired sample t test. RESULTS: (1) The positive rates of SIBO in pregnant women in the clinical hypothyroidism group and control group were 48.5% and 24.8%, respectively. (2) The incidence of abdominal distention and constipation in the clinical hypothyroidism group was significantly higher than that in the control group, and the risk of abdominal distention and constipation in SIBO-positive pregnant women was higher than that in SIBO-negative pregnant women. (3) The serum levels of hypersensitive C-reactive protein (hsCRP), IL-10, IL-6, TNF-α, low-density lipoprotein (LDL), total cholesterol (TC), free fatty acids (FFAs) and apolipoprotein B (ApoB) in the hypothyroidism group during pregnancy were higher than those in the control group. (4) After 21 days of probiotics combined with prebiotics, the incidence of pure methane positivity in the methane-hydrogen breath test in the G21 group was significantly reduced, and the average abundance of hydrogen and methane at each time point in the G21 group was lower than that in the G0 group. (5) The incidence of constipation in the G21 group was significantly lower than before treatment. (6) The levels of serum TSH, hsCRP, IL-6, TNF-α, TC and LDL in pregnant women after probiotics combined with prebiotics were lower than those before treatment. CONCLUSION: Probiotics combined with prebiotics are effective in the treatment of pregnant patients with clinical hypothyroidism complicated with SIBO, providing a new idea to treat pregnant patients with clinical hypothyroidism complicated with SIBO.
目的:探讨益生菌联合益生元对妊娠合并亚临床甲状腺功能减退症合并小肠细菌过度生长的临床疗效。
方法:(1)纳入 441 例孕妇,行乳果糖甲烷氢呼气试验,其中妊娠中期临床甲状腺功能减退症患者 231 例,正常妊娠孕妇 210 例,比较两组小肠细菌过度生长(SIBO)阳性率、胃肠道症状、甲状腺功能及炎症因子。(2)妊娠临床甲状腺功能减退症组 SIBO 阳性患者(n=112)在常规左甲状腺素钠片治疗基础上加用益生菌联合益生元,比较治疗前(G0)和治疗 21 天后(G21)甲烷氢呼气试验、胃肠道症状、甲状腺功能及炎症因子的变化,采用卡方检验和配对样本 t 检验。
结果:(1)临床甲状腺功能减退症组和对照组孕妇 SIBO 阳性率分别为 48.5%和 24.8%。(2)临床甲状腺功能减退症组腹胀、便秘发生率明显高于对照组,SIBO 阳性孕妇腹胀、便秘的发生风险高于 SIBO 阴性孕妇。(3)妊娠临床甲状腺功能减退症组超敏 C 反应蛋白(hsCRP)、白细胞介素 10(IL-10)、白细胞介素 6(IL-6)、肿瘤坏死因子-α(TNF-α)、低密度脂蛋白(LDL)、总胆固醇(TC)、游离脂肪酸(FFAs)、载脂蛋白 B(ApoB)水平均高于对照组。(4)益生菌联合益生元治疗 21 天后,G21 组纯甲烷阳性率明显降低,G21 组各时间点氢、甲烷平均丰度均低于 G0 组。(5)G21 组便秘发生率明显低于治疗前。(6)益生菌联合益生元治疗后孕妇血清 TSH、hsCRP、IL-6、TNF-α、TC、LDL 水平均低于治疗前。
结论:益生菌联合益生元治疗妊娠合并临床甲状腺功能减退症合并 SIBO 有效,为治疗妊娠合并临床甲状腺功能减退症合并 SIBO 提供了新的思路。
Probiotics Antimicrob Proteins. 2024-4
Front Endocrinol (Lausanne). 2021
Diabetes Res Clin Pract. 2021-6
Eur Rev Med Pharmacol Sci. 2017-11
World J Gastroenterol. 2012-11-7
Microorganisms. 2024-8-24
Acta Sci Pol Technol Aliment. 2021
J Altern Complement Med. 2021-2
J Clin Endocrinol Metab. 2020-12-1
Am J Obstet Gynecol. 2021-1
Nutrients. 2020-6-12
Clin Sci (Lond). 2020-6-26